ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Lawsuit: Brain Tumor Risks Linked to Birth Control Shot, Major Pharmaceutical Companies Sued

Las Vegas, NV, November 18, 2024 — A landmark lawsuit was filed today by the Dimopoulos Law Firm and Eglet Law Group in Nevada’s District Court against Pfizer and several generic pharmaceutical manufacturers, including Viatris, Greenstone, Prasco, and Pharmacia & Upjohn Co., on behalf of a woman who claims to have developed multiple brain tumors directly linked to the use of Depo-Provera, a widely prescribed contraceptive injection.

The lawsuit contends that these companies neglected to adequately warn consumers of known risks associated with the drug, which is marketed under the name “Depo Shot.”

Click here to view and download the complaint: https://stevedimopoulos.com/depo-provera-complaint-filing

According to the complaint, Depo-Provera caused the plaintiff to suffer “serious and potentially debilitating intracranial meningiomas” after years of regular use.

The plaintiff alleges that despite mounting evidence, the companies failed to include warnings on U.S. labels about this risk, even as labels in Canada and the European Union began to do so.

The complaint asserts that the defendants knew or should have known of the “highly increased risk of brain tumors,” based on “decades of scientific literature” that documented a correlation between high-dose progestin contraceptives and brain tumor development.

“Women trust pharmaceutical companies to prioritize their health, and if that trust is broken, we are here to help them seek justice,” said attorney Robert Eglet.

“We are committed to holding these companies accountable for the safety of their products,” said attorney Steve Dimopoulos.

The complaint highlights research published in the British Medical Journal earlier this year that found a 555% increased risk of intracranial meningiomas in patients who used Depo-Provera long-term, a finding cited as further evidence that the defendants failed to adequately inform consumers and the medical community in the U.S.

The suit also claims that in July 2024, U.S. labels for Depo-Provera were updated but still did not include a warning about meningiomas, despite the overwhelming body of research.

For individuals who believe they have been affected by Depo-Provera, more information is available at https://SteveDimopoulos.com/depo-provera-lawsuit/.

Media Contact:

Matt Shupe

Praetorian Public Relations

1615 Bonanza St, Walnut Creek, CA 94596

(415) 735-8491

Praetorian Public Relations

Originally Posted On: https://syndication.cloud/lawsuit-brain-tumor-risks-linked-to-birth-control-shot-major-pharmaceutical-companies-sued/

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.